Evaluation of a Virtual Reality Tool for Identifying the Cognitive Functions of the Right Hemisphere in Patients With Glioma -TANGO (TANGO)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04288505 |
Recruitment Status :
Recruiting
First Posted : February 28, 2020
Last Update Posted : June 4, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Brain Tumor Virtual Reality | Diagnostic Test: VIRTUAL REALITY application | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 36 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Diagnostic |
Official Title: | Evaluation of a Virtual Reality Tool for Identifying the Cognitive Functions of the Right Hemisphere in Patients With Glioma -TANGO |
Actual Study Start Date : | May 28, 2020 |
Estimated Primary Completion Date : | February 20, 2024 |
Estimated Study Completion Date : | March 1, 2024 |

Arm | Intervention/treatment |
---|---|
Experimental: single arm |
Diagnostic Test: VIRTUAL REALITY application
application on virtual reality headset |
- PERFORMANCE OF the VR APPLICATION compared to classic cognitive tests batery for the detection of cognitive deficit [ Time Frame: from surgery to 3 months after surgery ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Indication for glioma surgery
- Karnofsky > 70
Exclusion Criteria:
-

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04288505
Contact: Jean Michel Lemee | +33241356786 | JMLemee@chu-angers.fr |
France | |
University hospital | Recruiting |
Angers, France, 49000 | |
Contact: Jean Michel LEMEE +33241356786 JMLemee@chu-angers.fr |
Responsible Party: | University Hospital, Angers |
ClinicalTrials.gov Identifier: | NCT04288505 |
Other Study ID Numbers: |
2020-A00074-35 |
First Posted: | February 28, 2020 Key Record Dates |
Last Update Posted: | June 4, 2020 |
Last Verified: | April 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Brain Neoplasms Neoplasms Central Nervous System Neoplasms Nervous System Neoplasms |
Neoplasms by Site Brain Diseases Central Nervous System Diseases Nervous System Diseases |